ADMA
ADMA Biologics Inc
9.70$
-1.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | +1,248.5% | -57.5% | |
| – | +89.6% | -0.1% | +473.3% | +28.0% | -5.5% | +21.0% | +39.4% | +29.4% | +17.1% | -3.4% | +0.6% | |
| – | +37.1% | -26.9% | +24.9% | +42.4% | +19.2% | +7.7% | +22.2% | +49.5% | +18.6% | +120.1% | +47.1% | |
| – | +65.9% | -49.7% | +93.4% | -3.0% | +21.8% | -36.9% | +105.8% | +312.7% | – | – | – | |
| – | -477.2% | – | – | – | – | – | – | – | – | – | – | |
| – | -98.9% | +181.6% | +3,545.7% | -21.7% | +81.9% | +233.9% | +6.2% | +3.0% | -64.2% | +72.2% | +163.3% | |
| – | -56.9% | – | +1,581.9% | -113.8% | +81.9% | +233.8% | +6.2% | +3.0% | -64.2% | +72.2% | +155.3% | |
| – | – | – | – | – | – | – | – | +4,606.1% | – | – | – | |
| – | – | +25.2% | +203.9% | +9.6% | +12.8% | +170.7% | -100.0% | +4,606.1% | -51.2% | – | – | |
| – | -258.5% | -99.6% | – | -100.2% | – | -60.6% | -100.3% | – | -148.2% | +154.2% | -98.4% | |
| – | +6.2% | +61.9% | +260.8% | -29.3% | +86.4% | +79.9% | -15.9% | -10.1% | -135.8% | +49.5% | -24.5% | |
| – | – | – | – | -156.5% | – | – | -116.6% | – | -199.3% | – | -130.0% | |
| – | – | – | – | – | – | – | – | – | – | +2,782.9% | -74.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.